Dolby Laboratories, Inc. (DLB) 의 후행 P/E는 23.9, 선행 P/E 14.3. 후행 이익수익률은 4.18%, 선행 이익수익률 7.00%. PEG 0.22 (Peter Lynch 저평가 ≤1.0). 그레이엄 넘버는 $39.31.
이 페이지에서 입증된 기준:
SharesGrow 종합 점수: 75/100 5/7 개 기준 통과.
| Year | P/E (TTM) | PEG 비율 | P/B 비율 | P/S 비율 | 배당 수익률 |
|---|---|---|---|---|---|
| 2016 | 29.4 | 5.15 | 2.78 | 5.33 | 0.89% |
| 2017 | 29.0 | 4.13 | 2.74 | 5.41 | 0.97% |
| 2018 | 171.6 | -4.25 | 3.27 | 6.79 | 0.92% |
| 2019 | 25.7 | 0.23 | 2.85 | 5.29 | 1.18% |
| 2020 | 28.8 | -3.44 | 2.74 | 5.74 | 1.33% |
| 2021 | 28.7 | 0.86 | 3.43 | 6.95 | 1.00% |
| 2022 | 35.4 | -0.88 | 2.90 | 5.20 | 1.54% |
| 2023 | 37.8 | 4.35 | 3.22 | 5.84 | 1.36% |
| 2024 | 27.9 | 0.75 | 2.95 | 5.74 | 1.57% |
| 2025 | 27.2 | -9.32 | 2.65 | 5.14 | 1.82% |
| Year | EPS (희석) | 매출 | 순이익 | 순이익률 |
|---|---|---|---|---|
| 2017 | $1.95 | $1.08B | $201.8M | 18.7% |
| 2018 | $1.14 | $1.17B | $122.25M | 10.4% |
| 2019 | $2.44 | $1.24B | $255.15M | 20.5% |
| 2020 | $2.25 | $1.16B | $231.36M | 19.9% |
| 2021 | $2.97 | $1.28B | $310.23M | 24.2% |
| 2022 | $1.81 | $1.25B | $184.09M | 14.7% |
| 2023 | $1.96 | $1.01B | $191.47M | 19% |
| 2023 | $1.96 | $1.3B | $200.66M | 15.4% |
| 2024 | $3.71 | $1.27B | $360.64M | 28.3% |
| 2025 | $2.62 | $1.35B | $255.02M | 18.9% |
| Year | EPS (평균) | EPS 범위 | 매출 (평균) | 매출 범위 | 애널리스트 수 |
|---|---|---|---|---|---|
| 2026 | $4.34 | $4.31 – $4.37 | $1.42B | $1.41B – $1.43B | 3 |
| 2027 | $4.63 | $4.58 – $4.69 | $1.47B | $1.46B – $1.49B | 3 |
| 2028 | $5.08 | $5.03 – $5.15 | $1.56B | $1.54B – $1.57B | 1 |
